Literature DB >> 10529242

Kinetics and thermodynamics of dimer formation and dissociation for a recombinant humanized monoclonal antibody to vascular endothelial growth factor.

J M Moore1, T W Patapoff, M E Cromwell.   

Abstract

The recombinant humanized antibody (rhuMAb) VEGF has a high affinity for vascular endothelial growth factor and is currently being evaluated in clinical trials as a cancer therapeutic. Under acidic pH and low ionic strength conditions, the antibody was predominantly present as monomer. Under physiological conditions, the appearance of significant amounts of a noncovalent, reversible dimer were observed by size-exclusion chromatography. The kinetics and thermodynamics of the reversible self-association for rhuMAb VEGF monomer were investigated as a function of pH, temperature, and ionic strength by size-exclusion chromatography using the concentration jump method. The rate constant for dimer formation ranged 23-112 M(-)(1) min(-)(1) under the conditions studied, values that are significantly lower than those reported in the literature for other proteins that self-associate. The rate constant for dissociation ranged 0.0039-0.021 min(-)(1). Gibbs' free energies, enthalpies, entropies, and activation energies were determined and revealed that dimer formation is optimal at pH 7.5-8.0, which may be reflective of charge shielding occurring near the pI of the protein. There was a negative change in entropy for dissociation (values from -18.1 to -12.8 cal/mol K). In the presence of D(2)O or 1 M NaCl, dimerization was enhanced. The results of the kinetic and thermodynamic analysis of this study indicate that rhuMAb VEGF dimerization occurs primarily through hydrophobic interactions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529242     DOI: 10.1021/bi9905516

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  23 in total

1.  The association−dissociation behavior of the ApoE proteins: kinetic and equilibrium studies.

Authors:  Kanchan Garai; Carl Frieden
Journal:  Biochemistry       Date:  2010-11-09       Impact factor: 3.162

2.  Structure and function of purified monoclonal antibody dimers induced by different stress conditions.

Authors:  Rajsekhar Paul; Alexandra Graff-Meyer; Henning Stahlberg; Matthias E Lauer; Arne C Rufer; Hermann Beck; Alexandre Briguet; Volker Schnaible; Thomas Buckel; Sabine Boeckle
Journal:  Pharm Res       Date:  2012-04-05       Impact factor: 4.200

Review 3.  Is any measurement method optimal for all aggregate sizes and types?

Authors:  John S Philo
Journal:  AAPS J       Date:  2006-09-08       Impact factor: 4.009

Review 4.  Role of analytical ultracentrifugation in assessing the aggregation of protein biopharmaceuticals.

Authors:  Steven A Berkowitz
Journal:  AAPS J       Date:  2006-09-22       Impact factor: 4.009

Review 5.  Protein aggregation and bioprocessing.

Authors:  Mary E M Cromwell; Eric Hilario; Fred Jacobson
Journal:  AAPS J       Date:  2006-09-15       Impact factor: 4.009

6.  Lipid contribution to the affinity of antigen association with specific antibodies conjugated to liposomes.

Authors:  Melvin E Klegerman; Shaoling Huang; Devang Parikh; Janet Martinez; Sasha M Demos; Hayat A Onyuksel; David D McPherson
Journal:  Biochim Biophys Acta       Date:  2007-04-14

7.  Characterizing Thermal Transitions of IgG with Mass Spectrometry.

Authors:  Christopher J Brown; Daniel W Woodall; Tarick J El-Baba; David E Clemmer
Journal:  J Am Soc Mass Spectrom       Date:  2019-07-30       Impact factor: 3.109

8.  Ion-specific modulation of protein interactions: anion-induced, reversible oligomerization of a fusion protein.

Authors:  Yatin R Gokarn; R Matthew Fesinmeyer; Atul Saluja; Shawn Cao; Jane Dankberg; Andrew Goetze; Richard L Remmele; Linda O Narhi; David N Brems
Journal:  Protein Sci       Date:  2009-01       Impact factor: 6.725

9.  Thermodynamic and structural characterization of an antibody gel.

Authors:  Osigwe Esue; Anna X Xie; Tim J Kamerzell; Thomas W Patapoff
Journal:  MAbs       Date:  2013-02-20       Impact factor: 5.857

10.  Structural analysis of a therapeutic monoclonal antibody dimer by hydroxyl radical footprinting.

Authors:  Galahad Deperalta; Melissa Alvarez; Charity Bechtel; Ken Dong; Ross McDonald; Victor Ling
Journal:  MAbs       Date:  2012-12-17       Impact factor: 5.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.